Hyperion Defi (HYPD) Share-based Compensation (QoQ) (2017 - 2026)
Hyperion Defi (HYPD) Share-based Compensation (QoQ) (2017 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Hyperion Defi | 44.65 Mn | 35.01 Mn | 357,693.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -3.46% |
| Mar 31, 2026 | -86.90% |
| Mar 31, 2025 | -77.94% |
| Jun 30, 2024 | 331.78% |
| Mar 31, 2024 | -4.54% |
| Dec 31, 2023 | -6.65% |
| Sep 30, 2023 | 24.18% |
| Jun 30, 2023 | 40.85% |
| Mar 31, 2023 | -60.65% |
| Dec 31, 2022 | -4.09% |
| Sep 30, 2022 | -10.43% |
| Jun 30, 2022 | 14.07% |
| Mar 31, 2022 | 11.62% |
| Dec 31, 2021 | 4.75% |
| Sep 30, 2021 | 21.98% |
| Jun 30, 2021 | -2.98% |
| Mar 31, 2021 | 0.10% |
| Dec 31, 2020 | 7.59% |
| Sep 30, 2020 | -3.67% |
| Jun 30, 2020 | 8.44% |